Bone marrow transplantation corrects haemolytic anaemia in a novel ENU mutagenesis mouse model of TPI deficiency.
Ashlee J ConwayFiona C BrownElinor J HortleGaetan BurgioSimon J FooteCraig J MortonStephen M JaneDavid J CurtisPublished in: Disease models & mechanisms (2018)
In this study, we performed a genome-wide N-ethyl-N-nitrosourea (ENU) mutagenesis screen in mice to identify novel genes or alleles that regulate erythropoiesis. Here, we describe a recessive mouse strain, called RBC19, harbouring a point mutation within the housekeeping gene, Tpi1, which encodes the glycolysis enzyme, triosephosphate isomerase (TPI). A serine in place of a phenylalanine at amino acid 57 severely diminishes enzyme activity in red blood cells and other tissues, resulting in a macrocytic haemolytic phenotype in homozygous mice, which closely resembles human TPI deficiency. A rescue study was performed using bone marrow transplantation of wild-type donor cells, which restored all haematological parameters and increased red blood cell enzyme function to wild-type levels after 7 weeks. This is the first study performed in a mammalian model of TPI deficiency, demonstrating that the haematological phenotype can be rescued.
Keyphrases
- red blood cell
- wild type
- bone marrow
- genome wide
- mouse model
- crispr cas
- mesenchymal stem cells
- gene expression
- dna methylation
- stem cells
- endothelial cells
- amino acid
- oxidative stress
- cell therapy
- metabolic syndrome
- cell cycle arrest
- skeletal muscle
- copy number
- high fat diet induced
- insulin resistance
- cell proliferation
- replacement therapy